Staphylococcus argenteus transmission among healthy Royal Marines: A molecular epidemiology case-study.


Journal

The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424

Informations de publication

Date de publication:
11 2021
Historique:
received: 27 05 2021
revised: 03 08 2021
accepted: 26 08 2021
pubmed: 2 9 2021
medline: 15 12 2021
entrez: 1 9 2021
Statut: ppublish

Résumé

Objectives During a prospective study of S. aureus carriage in Royal Marines recruits, six S. argenteus strains were identified in four recruits. As S. argenteus sepsis leads to mortality similar to S. aureus, we determined the potential for within same troop transmission, to evaluate future outbreak risk. Methods We used whole-genome sequencing to characterise S. argenteus and investigate phylogenetic relationships between isolates. Results S. argenteus strains (t5078, ST2250) were detected in 4/40 recruits in the same troop (training cohort) in weeks 1, 6 or 15 of training. No mec, tsst or LukPV genes were detected. We identified differences of 1-17 core SNPs between S. argenteus from different recruits. In two recruits, two S. argenteus strains were isolated; these could be distinguished by 2 and 15 core SNPs. Conclusions The identification of S. argenteus within a single troop from the total recruit population suggests a common source for transmission, though high number of SNPs were identified, both within-host and within-cluster. The high number of SNPs between some isolates may indicate a common source of diverse isolates or a high level of S. argenteus mutation in carriage. S. argenteus is newly recognized species; and understanding of the frequency of genetic changes during transmission and transition from asymptomatic carriage to disease is required.

Identifiants

pubmed: 34469709
pii: S0163-4453(21)00444-8
doi: 10.1016/j.jinf.2021.08.040
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

550-553

Subventions

Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors have no competing interests to declare.

Auteurs

Elita Jauneikaite (E)

Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Faculty of Medicine, Imperial College London, London W2 1PG, UK. Electronic address: e.jauneikaite@imperial.ac.uk.

Bruno Pichon (B)

NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Faculty of Medicine, Imperial College London, London W2 1PG, UK; Healthcare Associated Infection and Antimicrobial Resistance, National Infection Service, Public Health England, Colindale, UK.

Mia Mosavie (M)

NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Faculty of Medicine, Imperial College London, London W2 1PG, UK.

Joanne L Fallowfield (JL)

Institute of Naval Medicine, Alverstoke, UK.

Trish Davey (T)

Institute of Naval Medicine, Alverstoke, UK.

Neil Thorpe (N)

Institute of Naval Medicine, Alverstoke, UK.

Andrew Nelstrop (A)

Commando Training Centre Royal Marines, Lympstone, UK; Defence Primary Healthcare, Plymouth, UK.

Shiranee Sriskandan (S)

NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Faculty of Medicine, Imperial College London, London W2 1PG, UK.

Lucy E Lamb (LE)

NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Faculty of Medicine, Imperial College London, London W2 1PG, UK; Academic Department of Military Medicine, Royal Centre for Defence Medicine (Research and Academia), Birmingham, UK; Royal Free London NHS Foundation Trust, London NW3 2QG, UK. Electronic address: lucylamb@nhs.net.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH